戻る Agenda
Balancing Regulatory, Medical, and Operational Pillars to Get Pediatric Trials Done Globally
Session Chair(s)
Earl Seltzer, MBA
Senior Director, Partnerships and Innovation
CTI, United States
Planning for pediatric trials requires a deep understanding of the regulatory, medical, and operational aspects of study conduct in order to ensure these trials are conducted as sufficient as possible. This session will include members of a CRO and developer space.
Learning Objective : Evaluate and characterize the risk profile of pediatric clinical trials; Establish a realistic operational delivery strategy in light of the risk profile; Identify the medical, regulatory, and operational barriers to pediatric clinical trial feasibility on a global scale.
Speaker(s)
Initiation and Development of Pediatric Clinical Trials: Regulatory and Ethical Issues
Donna Snyder, MD
WCG, United States
Executive Physician
DIY Toy Box: Operational Considerations and Insights for Pediatric Clinical Trials
Gina Calarco, BSN, MPH
IQVIA, United States
Senior DIrector, Clinical Scientific Lead